Health Care M&A Deals, Week Ending October 19, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Novartis AG Endocyte, Inc. $2.1 billion Roche Collaboration on cellular therapy $125 million AbbVie Inc. Collaboration targeting fibrotic diseases $100 million Sarepta Therapeutics, Inc. License to gene therapy for Sanfilippo syndrome $15 million... Read More »Health Care M&A Deals, Week Ending October 12, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Gurnet Point Capital Corium International, Inc. $624 million Roche Collaboration on IONIS-FB-Lrx $75 million Breathtec Biomedical Inc. Nash Pharmaceuticals $3.8 million Carrick Therapeutics License to BTG945 N/A MeiraGTx Holdings plc Vector... Read More »
Health Care M&A Deals, Week Ending October 8, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Varsity Healthcare Partners Ideal Option N/A BrightSpring Health Services Gateway Pediatric Therapy N/A Biotechnology Acquirer Target Price Boston Pharmaceuticals, Inc. License to three novel anti-infective programs... Read More »
September Health Care Deal Results
September is usually a frantic, frenetic transition month, as vacations end, families’ lives kick into high(er) gear, and we face the inexorable onslaught of the winter months in the Northern Hemisphere. On that plane, the healthcare M&A market proved to be remarkably tame for the month. Starting from the high-level view, deal volume currently stands at 126 transactions, slightly lower than the previous month and the year-ago month. But not by a lot. If you can even remember August, it was itself a frantic month, thanks to the Long-Term Care sector, which posted a record 49 transactions. The 25 deals now on record for September are still preliminary, and we expect some revisions upward... Read More »
Third Quarter Healthcare Deal Results
Healthcare deals just keep coming. For the third consecutive quarter, deal volume topped the 400 mark, and those are just preliminary results. As we went to press, 417 deals are on the books, and more will be added as they come to light. Although that total is down 11% compared with the scorching results from the second quarter (471 deals), it’s 8% higher than the same quarter in 2017 (386 deals), and 5% better than the fourth quarter in 2017 (396 deals). The Services sectors showed their usual strength, making up 63% of Q3:18’s deal volume. Once again, the Long-Term Care sector dominated the chart with 102 deals reported, and more to come. Some 110 Long-Term Care deals were reported in... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
